|Status : Published||Published On : Oct, 2021||Report Code : VRHC1203||Industry : Healthcare||Available Format :||Page : 200|
The global minimally invasive gastrointestinal surgical systems market is witnessing substantial growth i.e., from USD 5.02 billion in 2020 to USD 9.34 billion by 2027, registering a CAGR of 6.7% during the forecast period 2021-2027. The mounting cases of GI disorders, advantages offered by minimally invasive gastrointestinal surgery, mounting R&D investment, technologically development in MIS and robotics-based surgeries, rising number of surgical processes owing to the rising geriatric population, and rising prevalence of chronic diseases are the factors that are the factors that bolster the growth of the global minimally invasive gastrointestinal surgical system market. Moreover, the rising geriatric population requires minimally invasive surgeries owing to less blood loss, postoperative mobilization, and reduced stay at hospitals and provides high precision and control during surgical procedures, resulting in the growth of the minimally invasive gastrointestinal surgical system market.
The COVID-19 pandemic has had an adverse effect on the global economy and public health. The virus has forced organizations to change the way businesses operate. Robotic assistance can be adopted in the Minimally Invasive Gastrointestinal Surgical System during the pandemic. Moreover, the rising pressure to hospitalize COVID-19 patients has led to the re-profiling of various hospitals and departments to treat COVID-19 patients. This led to the cancellation or postponement of elective surgeries owing to limited capacities and resources.
Insight by Product Type
Based on product type, the minimally invasive gastrointestinal surgical systems market is divided into conventional minimally invasive gastrointestinal surgical systems (MISS) and surgical robots. The conventional minimally invasive gastrointestinal surgical systems (MISS) are sub-divided into endoscopes and endoscopy systems, videoscopes, endoscopic ultrasound, therapeutic energy devices. The endoscopes and endoscopy systems are further sub-divided into rigid endoscopes, flexible endoscopes, and capsule endoscopy. The surgical robots are sub-divided into robotic systems, robotic surgery instruments and accessories, and services. Endoscopes and Endoscopy are widely used in Minimally Invasive Gastrointestinal Surgical Systems (MISS) and have significant growth as it allows clinicians to examine the structure inside the body like urethra, GI tract, esophagus, stomach, small intestine, and colon. Moreover, the provides clinicians to perform keyhole surgeries and make small precision through Minimally Invasive surgery.
Insight by Surgery Type
Based on surgery type, the minimally invasive gastrointestinal surgical systems market is divided into adrenalectomy, appendectomy, bariatric surgery, cholecystectomy, colon, and rectal surgery, foregut surgery, and hernia repair. Appendectomy is a surgery that is done when the appendix becomes infected and inflamed, there is a need to remove it, and is anticipated to grow at a faster pace owing to the rising prevalence of appendicitis and growing demand for diagnostic and treatment options for appendicitis. The colon and rectal surgery segment is also anticipated to grow at a high CAGR as it treats conditions of the larger intestine (colon, rectum, and anus). Moreover rising incidences of colorectal cancer due to unhealthy food habits and odd food consumption timings, rising number of clinical trials to innovate new drugs, growing geriatric population are the factors for the growth of the colon and rectal surgery segment.
Insight by End-User
Based on end-user, the global minimally invasive gastrointestinal surgery market is categorized into specialty clinics, hospitals, and ambulatory surgical centers. The ambulatory surgical center is an imperative part as it provides a safe, patient-friendly, and cost-effective environment for the establishment of healthcare services such as colorectal cancer screening coloscopy.
Factors that can propel the growth of the minimally invasive gastrointestinal surgical system market include benefits of minimally invasive surgical procedures i.e., smaller incisions, high precision, enhanced vision during surgical procedures, fewer complications, reduced operating time over conventional open surgical procedures. Moreover, accessibility of technologically developed products in the field of GI surgical procedures, mounting spending on healthcare, rising complexities in clinical decision-making, increasing workload of radiologists, and increasing adoption of robotics in GI surgical procedures are the other factors that have bolstered the growth of minimally invasive gastrointestinal surgical system market.
Lack of trained professionals, the huge cost involved in minimally invasive GI surgical procedures, restraining reimbursement framework are the challenges that have hampered the growth of the minimally invasive gastrointestinal surgical system market.
The increasing mergers & acquisitions to expand surgical robotic systems, advancement of long-distance teleoperated surgical robotic systems, rising investment geographically, and technological development of surgical robotic systems will create lucrative opportunities in the minimally invasive gastrointestinal surgical system market.
North America dominates the minimally invasive gastrointestinal surgical system market owing to the rising prevalence of GI disorders, advantages of minimally invasive GI surgery, massive R&D investment, technological development in MIS, and robot-based surgeries.
Asia-Pacific is anticipated to grow at a faster pace owing to development and advancement in healthcare infrastructure, promising results in surgery assistance will fuel the growth of the minimally invasive gastrointestinal surgical system market in the region.
The industry players are focusing on collaboration, alliances, business expansion, mergers & acquisitions, and partnerships with companies and universities, and research institutes to develop and innovate minimally invasive gastrointestinal surgical systems and strengthen their position in the market.
Ambu Inc. has received approval from Health Canada for aScope 4 Cysto, a single-use endoscopes platform for urology.
FUJIFILM Medical Systems U.S.A., Inc., announced the launch of the new ELUXEO Surgical System, an innovative equipment tower comprised of products from the company’s endoscopy and minimally invasive surgery portfolios.
Some of the key players operating in the minimally invasive gastrointestinal surgical system market: Olympus Corporation, B. Braun Melsungen AG, Karl Storz SE & Co. KG, FUJIFILM Holdings Corporation, Ambu A/S, Medtronic, Intuitive Surgical, Stryker, Asensus Surgical US, Inc., and Xenocor, Inc.
Source: VynZ Research